No Intervention for this observational study clinical trials

PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency

This study aims to understand rare conditions called ENPP1 Deficiency and ABCC6 Deficiency. Researchers will gather information from medical records and routine check-ups to learn more about how these conditions develop and affect people over time. It's an observational study, meaning there's no new treatment or intervention.